Probity Advisors Inc. Invests $304,000 in Phreesia, Inc. (NYSE:PHR)

Probity Advisors Inc. purchased a new position in Phreesia, Inc. (NYSE:PHR - Free Report) during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The firm purchased 12,074 shares of the company's stock, valued at approximately $304,000.

Several other hedge funds have also made changes to their positions in PHR. PharVision Advisers LLC acquired a new position in shares of Phreesia during the 4th quarter valued at $302,000. Two Sigma Advisers LP acquired a new position in shares of Phreesia in the 4th quarter worth $302,000. Silvercrest Asset Management Group LLC grew its holdings in shares of Phreesia by 31.0% in the 4th quarter. Silvercrest Asset Management Group LLC now owns 394,352 shares of the company's stock worth $9,922,000 after acquiring an additional 93,349 shares during the last quarter. ProShare Advisors LLC grew its holdings in shares of Phreesia by 49.0% in the 4th quarter. ProShare Advisors LLC now owns 15,585 shares of the company's stock worth $392,000 after acquiring an additional 5,127 shares during the last quarter. Finally, Nuveen Asset Management LLC grew its holdings in shares of Phreesia by 77.1% in the 4th quarter. Nuveen Asset Management LLC now owns 235,827 shares of the company's stock worth $5,933,000 after acquiring an additional 102,662 shares during the last quarter. Institutional investors own 92.10% of the company's stock.

Phreesia Stock Up 0.5%

PHR traded up $0.12 during trading on Friday, reaching $24.55. 672,417 shares of the stock traded hands, compared to its average volume of 446,701. Phreesia, Inc. has a fifty-two week low of $17.07 and a fifty-two week high of $30.53. The stock's 50-day simple moving average is $24.80 and its two-hundred day simple moving average is $25.26. The stock has a market cap of $1.46 billion, a price-to-earnings ratio of -16.70 and a beta of 0.74. The company has a debt-to-equity ratio of 0.04, a current ratio of 1.74 and a quick ratio of 1.74.

Phreesia (NYSE:PHR - Get Free Report) last announced its quarterly earnings results on Wednesday, May 28th. The company reported ($0.07) earnings per share for the quarter, topping analysts' consensus estimates of ($0.13) by $0.06. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $115.94 million during the quarter, compared to analysts' expectations of $115.00 million. During the same quarter in the previous year, the firm earned ($0.05) earnings per share. The business's quarterly revenue was up 14.5% compared to the same quarter last year. As a group, equities research analysts expect that Phreesia, Inc. will post -1.1 EPS for the current year.

Analyst Ratings Changes

PHR has been the topic of a number of recent research reports. Wall Street Zen cut Phreesia from a "buy" rating to a "hold" rating in a report on Saturday, May 24th. Canaccord Genuity Group lowered their price target on Phreesia from $35.00 to $34.00 and set a "buy" rating on the stock in a report on Thursday. Needham & Company LLC reiterated a "buy" rating and set a $29.00 price target on shares of Phreesia in a report on Thursday, March 13th. Citigroup reiterated a "buy" rating on shares of Phreesia in a report on Wednesday. Finally, DA Davidson lowered their price target on Phreesia from $36.00 to $34.00 and set a "buy" rating on the stock in a report on Monday, April 14th. One equities research analyst has rated the stock with a hold rating and twelve have given a buy rating to the company's stock. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $31.33.

Insiders Place Their Bets

In other news, General Counsel Allison C. Hoffman sold 3,496 shares of Phreesia stock in a transaction dated Monday, March 17th. The stock was sold at an average price of $25.32, for a total value of $88,518.72. Following the transaction, the general counsel now directly owns 139,134 shares in the company, valued at approximately $3,522,872.88. The trade was a 2.45% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CFO Balaji Gandhi sold 8,045 shares of Phreesia stock in a transaction dated Tuesday, April 8th. The stock was sold at an average price of $23.85, for a total value of $191,873.25. Following the completion of the transaction, the chief financial officer now owns 108,411 shares in the company, valued at $2,585,602.35. The trade was a 6.91% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 42,474 shares of company stock valued at $1,023,208 over the last quarter. Insiders own 5.50% of the company's stock.

Phreesia Company Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.